All times in this program are Central European Time (UTC+1)
| Timing | Title suggestions | Speaker suggestions |
|---|---|---|
| 9:45-10:00 AM | Meeting opening Bridging supportive care and anti-cancer therapy | Jean-Charles Soria (Villejuif)) |
| 10:00-10:30 AM | PLENARY SESSION DAILY DRUGS, MICROBIOTA & CANCER DRUGS: PARTNERS OR ENEMY – DANGEROUS LIAISONS? | Joël Epstein (Duarte, USA) |
| 10:00-10:15 AM | Daily drugs; Antibiotics, IPP, Statins, steroids, etc. | Denis Moro-Sibilot (Grenoble) |
| 10:15-10:30 AM | The gut microbiota in the modulation of anticancer drugs efficacy and toxicity : last data | Lisa De Rosa (Villejuif) |
| 10:30-11:15 AM | PLENARY SESSION COVID 19 : THE STORM OF CANCER CARE | Mario Dicato (Luxembourg) |
| 10:30-10:45 AM | The impact of pandemic on Ethics and Cancer Care | Matti Aapro (Switzerland) |
| 10:45-11:00 AM | The impact on supportive management | Andrew Davies (UK) |
| 11:00-11:15 AM | Discussion | |
| 11:15-11:30 AM | Break |
|
| 11:30-12:15 AM | PLENARY SESSION NEW DRUGS & SAFETY / TUMOR LOCALIZATION | Pere Gascon (Spain) |
| 11:30-11:45 AM | Gynecology | Isabelle Ray-Coquard (Lyon) |
| 11:45-12:00 AM | Haemato-Oncology | Stéphane Chèze (Caen) |
| 12:00-12:15 AM | Urology | Yann Vano (Paris) |
| 12:15-1:00 PM |  PLENARY SESSIONSUPPORTIVE AND SURVIVORSHIP CARE NEEDS AFTER CANCER TREATMENT– With the institutional support of Pfizer | Rajesh Lalla (Connecticut) |
| 12:15-12:30 AM | Definition and guidelines | Maryam Lustberg (USA) |
| 12:30-12:45 AM | Canto: A new model for research | Ines Vaz Luis (Villejuif) |
| 12:45-01:00 PM | Patient’s experience and unmet needs | Patient |
| 1:00-2:00 PM | Lunch | |
| 2:00-3:00 PM |  PLENARY SESSIONDIGITAL HEALTH (UPDATE) AND CANCER CONTINUUM – With the institutional support of Viatris | Olivier Mir (Villejuif) |
| 2:00-2:15 PM | Digital Health for Symptom Monitoring | Ethan Basch (USA) |
| 2:15-2:30 PM | Running to daily practice | Fabrice Denis (Le Mans) |
| 2:30-2:45 PM | A review of digital programs | Paolo Bossi (Brescia) |
| 2:45-3:00 PM | From hospital to home care and back | Mario Di Palma (Paris) |
| 3:00-3:30 PM | Break |
|
| 3:30-4:00 PM |  SYMPOSIUMTOXICITES DES IMMUNOTHERAPIES AU STADE ADJUVANT : DE LA THEORIE A LA PRATIQUE | Ariane Laparra-Ramakichenin (Le Kremlin-Bicêtre) Raffaele Ratta (Suresnes) |
| 4:00-5:30 PM | CONTROVERSIES AND DIFFERENT APPROACHES | Fausto Roila (Italy) & Richard Gralla (USA) |
| 4:00-4:30 PM | Is cancer a matter of bad luck? | Mario Dicato (Luxembourg) |
| 4:30-5:00 PM | Different approaches: CINV, best association from acute to breakthrough | Richard Gralla (USA), R. Navari (Birmingham) |
| 5:00-5:30 PM | Controversies: Febrile Neutropenia, MASCC tool evidence vs ASCO | Jean Klastersky (Brussels), B. L. Rapoport (South Africa) |
| 5:30-6:15 PM | YOUNG PHYSICIAN AWARD JEAN KLASTERSKY Presentation of the 3 first clinical cases (3 x 15 min) | Moderators: Jean Klastersky (Brussels), Paolo Bossi (Brescia), Richard Berman (UK), Richard Gralla (USA), Ivan Krakowski (Bordeaux). |
| Timing | Title suggestions | Speaker suggestions |
|---|---|---|
| 8:45-9:30 AM | YOUNG PHYSICIAN AWARD – JEAN KLASTERSKY Presentation of the 3 last clinical cases (3 x 15 min) | Moderators: Jean Klastersky (Brussels), Paolo Bossi (Brescia), Richard Berman (UK), Richard Gralla (USA), Ivan Krakowski (Bordeaux). |
| 9:30-10:30 AM | PLENARY SESSION OPTIMIZE CANCER CARE AND INNOVATIVE TREATMENTS IN ONCOLOGY | Jeffrey Crawford (USA) |
| 9:30-9:45 AM | New drugs expected in the next future (CAR T, Bispecific antibodies…) | Christophe Massard (Rennes) |
| 9:45-10:00 AM | New coming toxicities | Olivier Lambotte (Le Kremlin-Bicêtre) |
| 10:00-10:15 AM | Managing the safety | Jean-Marie Michot (Villejuif) |
| 10:15-10:30 AM | How to deal with frailty | Gilles Freyer (Lyon) |
| 10:30-11:00 AM |  PLENARY SESSIONLONG TERM SAFETY AFTER IMMUNE-ONCOLOGY – With the institutional support of MSD | Paolo Bossi (Brescia) |
| 10:30-10:40 AM | Long term toxicity: are they similar with the acute? | Edith Borcoman (Paris) |
| 10:40-10:50 AM | How to prevent / manage long term toxicity? | Delphine Loirat (Paris) |
| 10:50-11:00 AM | Monitoring interest | Paolo Bossi (Brescia) |
| 11:00-11:30 AM | Break |
|
| 11:30-12:00 AM |  SYMPOSIUMFEVER AND CANCER: THE ISSUE | Gilles Freyer (Lyon), Didier Mayeur (Dijon) |
| 12:00-12:30 PM | PLENARY SESSION VACCINATION AND SUPPORTIVE CARE IN CANCER DURING PANDEMICS AND BEYOND | Fausto Roila (Italy) |
| 12:00-12:15 PM | Covid vaccination: The MDAnderson experience | Ishwaria Mohan Subbiah (USA) |
| 12:15-12:30 PM | Covid Vaccine, what else? | Benjamin Wyplosz (Le Kremlin-Bicêtre) |
| 12:30-1:30 PM | Lunch |
|
| 1:30-2:30 PM | PLENARY SESSION NEW DRUGS & SAFETY / TUMOR LOCALIZATION | Richard Gralla (USA) |
| 1:30-1:45 PM | Lung | Nicolas Girard (Paris) |
| 1:45-2:00 PM | GI | Jérôme Desrame (Lyon) |
| 2:00-2:15 PM | Breast | Joseph Gligorov (Paris) |
| 2:15-2:30 PM | Session Q/R | |
| 2:30-3:00 PM |  THE NEW AFSOS STANDARDS – With the institutional support of LEO Pharma | Ismail Elalamy (Paris) |
| 3:00-3:30 PM | Break | |
| 3:30-3:45 PM | YOUNG PHYSICIAN AWARD – JEAN KLASTERSKY Award ceremony | Moderators: Jean Klastersky (Brussels), Paolo Bossi (Brescia), Richard Berman (UK), Richard Gralla (USA), Ivan Krakowski (Bordeaux). |
| 3:45-4:45 PM | PLENARY SESSION LET’S TALK ABOUT SEX | Richard Berman (UK) |
| 3:45-4:00 PM | Why to discuss and when – the main sexual complaints | Marion Aupomerol (Paris) |
| 4:00-4:15 PM | How to discuss | Richard Berman (UK) |
| 4:15-4:30 PM | How to manage The ASCO survey | Charles Stewart Kamen (USA), Mandi Chapman (USA), Shail Maingi (USA) |
| 4:45-5:00 PM | CONCLUSION | Florian Scotté (Villejuif) |
OUR
PARTNERS
